Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Declines By 46.5%

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 28,200 shares, a drop of 46.5% from the April 30th total of 52,700 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 165,000 shares, the days-to-cover ratio is presently 0.2 days.

Sysmex Stock Performance

Shares of OTCMKTS:SSMXY traded up $0.09 during midday trading on Friday, hitting $16.72. The company's stock had a trading volume of 96,837 shares, compared to its average volume of 71,411. The stock has a market capitalization of $10.53 billion, a price-to-earnings ratio of 29.86 and a beta of 1.22. The stock's 50 day simple moving average is $18.12 and its 200 day simple moving average is $18.68. Sysmex has a fifty-two week low of $14.38 and a fifty-two week high of $22.00. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.42 and a current ratio of 3.19.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.16 by ($0.04). The company had revenue of $958.89 million during the quarter, compared to analyst estimates of $991.22 million. As a group, research analysts anticipate that Sysmex will post 0.57 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.